Is Adjuvant Cellular Immunotherapy Essential after TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma? A Systematic Meta-Analysis of Studies Including 1774 Patients
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is Adjuvant Cellular Immunotherapy Essential after TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma? A Systematic Meta-Analysis of Studies Including 1774 Patients
Authors
Keywords
Hepatocellular carcinoma, Immunotherapy, Meta-analysis, Cancer treatment, Cancer immunotherapy, Publication ethics, Immune cells, Prognosis
Journal
PLoS One
Volume 11, Issue 12, Pages e0168798
Publisher
Public Library of Science (PLoS)
Online
2017-01-10
DOI
10.1371/journal.pone.0168798
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma
- (2016) Ke Yang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Current status and perspectives of immune-based therapies for hepatocellular carcinoma
- (2016) Maridi Aerts WORLD JOURNAL OF GASTROENTEROLOGY
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Surgical and Locoregional Therapy of HCC: TACE
- (2015) Masakatsu Tsurusaki et al. Liver Cancer
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- A meta-analysis of cytokine-induced killer cells therapy in combination with minimally invasive treatment for hepatocellular carcinoma
- (2014) Xiaofeng Li et al. Clinics and Research in Hepatology and Gastroenterology
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
- (2013) Penny F. Whiting ANNALS OF INTERNAL MEDICINE
- Cytokine-induced Killer Cells in Combination With Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Patients
- (2013) Zhi-Mei Huang et al. JOURNAL OF IMMUNOTHERAPY
- CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement
- (2012) Ming Zhao et al. EUROPEAN JOURNAL OF RADIOLOGY
- Adoptive Immunotherapy in Postoperative Hepatocellular Carcinoma: A Systemic Review
- (2012) Feng Xie et al. PLoS One
- Efficacy of transcatheter arterial chemoembolization combined with cytokine-induced killer cell therapy on hepatocellular carcinoma: a comparative study
- (2012) Ming-Zhi Hao et al. Chinese Journal of Cancer
- Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy
- (2012) Chang-Chuan Pan et al. Chinese Journal of Cancer
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Overview of Cellular Immunotherapy for Patients with Glioblastoma
- (2010) Elodie Vauleon et al. Clinical & Developmental Immunology
- Loco-regional treatment of hepatocellular carcinoma
- (2010) Riccardo Lencioni HEPATOLOGY
- Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting
- (2010) Melanie B. Thomas et al. JOURNAL OF CLINICAL ONCOLOGY
- Minimally Invasive Treatment Combined With Cytokine-induced Killer Cells Therapy Lower the Short-term Recurrence Rates of Hepatocellular Carcinomas
- (2009) De-Sheng Weng et al. JOURNAL OF IMMUNOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now